Abstract
Ricinus communis is a dual-use crop that produces both high-value ricinoleic acid (RA) and the potent toxin ricin. This narrative review (2015-2025) assessed process and biosafety strategies that enhance RA yields while preventing toxic exposures. PubMed, Scopus and SciELO searches followed SANRA-6 guidance; five core studies met inclusion criteria. Green enzymatic hydrolysis (Lipozyme TL IM, 45 °C, pH 7) achieved mean RA conversions of 96 % with negligible by-products. Autoclave-plus-washing protocols lowered residual ricin in castor meal to < 0.1 mg kg⁻¹, allowing up to 45 % substitution for soybean meal in sheep and goat diets without performance loss. Integrating Good Manufacturing Practices, Hazard Analysis and blockchain-based traceability forms a robust barrier against accidental or intentional poisoning, while opening avenues for anti-inflammatory dermocosmetics and nanostructured drug-delivery systems. Research gaps include randomized clinical trials on RA, standardized biomarkers of ricin exposure and CRISPR-engineered low-ricin cultivars. Process engineering, toxicology and governance thus converge to turn the castor paradox into a model of responsible bio-innovation.
References
ALQURASHI, R. M. et al. Consumption of a Flavonoid-Rich Açai Meal Is Associated With Acute Improvements in Vascular Function and a Reduction in Total Oxidative Status in Healthy Overweight Men. The American Journal of Clinical Nutrition, v. 104, n. 5, p. 1227-1235, 2016. DOI: 10.3945/ajcn.115.128728.
ALQURASHI, R. M. et al. Consumption of a flavonoid-rich açaí meal is associated with acute improvements in vascular function and a reduction in total oxidative status in healthy overweight men. American Journal of Clinical Nutrition, v. 104, n. 5, p. 1227-1235, 2016.
ARANHA, L. N. et al. Effects of a hypoenergetic diet associated with açaí (Euterpe oleracea Mart.) pulp consumption on antioxidant status, oxidative stress and inflammatory biomarkers in overweight, dyslipidemic individuals. Clinical Nutrition, v. 39, n. 5, p. 1464-1469, 2020.
FIGUEIREDO, A. M. et al. Açai Supplementation (Euterpe oleracea Mart.) Attenuates Cardiac Remodeling After Myocardial Infarction in Rats Through Different Mechanistic Pathways. PloS One, v. 17, n. 3, p. e0264854, 2022. DOI: 10.1371/journal.pone.0264854.
IMPELLIZZERI, D. et al. Molecular Targets for Anti-Oxidative Protection of Açaí Berry Against Diabetes Myocardial Ischemia/Reperfusion Injury. Free Radical Research, v. 57, n. 5, p. 339-352, 2023. DOI: 10.1080/10715762.2023.2243032.
KIM, H. et al. Açaí (Euterpe oleracea Mart.) beverage consumption improves biomarkers for inflammation but not glucose- or lipid-metabolism in individuals with metabolic syndrome in a randomized, double-blinded, placebo-controlled clinical trial. Food & Function, v. 9, n. 6, p. 3097-3103, 2018.
LIZ, S. de et al. Açaí (Euterpe oleracea Mart.) and Juçara (Euterpe Edulis Mart.) Juices Improved HDL-c Levels and Antioxidant Defense of Healthy Adults in a 4-Week Randomized Cross-Over Study. Clinical Nutrition (Edinburgh, Scotland), v. 39, n. 12, p. 3629-3636, 2020. DOI: 10.1016/j.clnu.2020.04.007.
MOURA, R. S. de; RESENDE, Â. C. Cardiovascular and Metabolic Effects of Açaí, an Amazon Plant. J. Cardiovasc. Pharmacol., v.68, n.1, p.19–26, 2016.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Journal of Advanced Clinical Implementation and Applied Medical Innovations